NeuroVive Developing New Prodrugs with Potential to Treat Mitochondrial Disease
A team of researchers at NeuroVive Pharmaceuticals developed a new pharmacological strategy that could potentially be used to treat mitochondrial disease.
Author Archives: Özge Özkaya, PhD
June 6, 2016
by Özge Özkaya, PhD
Case Study Details Rare Adult-Onset Leigh’s Disease Treatment
Researchers at Nizam's Institute of Medical Sciences in India reported a case of adult onset Leigh’s disease that showed dramatic improvement following treatment. This case study suggests that late onset Leigh’s disease may be treatable.
Recent Posts
- COVID-19 Delaying Rare Disease and Gene Therapy Trials, Pharma Execs Say
- Eurordis Urges Expansion of Newborn Screening Initiatives Across Europe
- Unity and EU-wide Efforts Focus of Online Rare Disease Meeting
- Vitamin B3 Boosts Muscle Health in Mitochondrial Myopathy, Study Suggests
- Rare Diseases Clinical Research Network Opens Online Survey on COVID-19